Related references
Note: Only part of the references are listed.Neoadjuvant Intraperitoneal and Systemic Chemotherapy for Gastric Cancer Patients with Peritoneal Dissemination
Yoshiyuki Fujiwara et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
The performance of expansile nanoparticles in a murine model of peritoneal carcinomatosis
Yolonda L. Colson et al.
BIOMATERIALS (2011)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Hyaluronic acid-paclitaxel: effects of intraperitoneal administration against CD44(+) human ovarian cancer xenografts
Ilaria De Stefano et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
Evaluation of combined bevacizumab and intraperitoneal carboplatin or paclitaxel therapy in a mouse model of ovarian cancer
Dhaval K. Shah et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
Spatial distribution of intraperitoneally administrated paclitaxel nanoparticles solubilized with poly (2-methacryloxyethyl phosphorylcholine-co n-butyl methacrylate) in peritoneal metastatic nodules
Takao Kamei et al.
CANCER SCIENCE (2011)
Gastric cancer treatment in Japan: 2008 annual report of the JGCA nationwide registry
Yoh Isobe et al.
GASTRIC CANCER (2011)
Phase II study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer with peritoneal metastasis
H. Ishigami et al.
ANNALS OF ONCOLOGY (2010)
Cell-penetrating macromolecules: Direct penetration of amphipathic phospholipid polymers across plasma membrane of living cells
Tatsuro Goda et al.
BIOMATERIALS (2010)
Targeted delivery for breast cancer therapy: the history of nanoparticle-albumin-bound paclitaxel
Fausto Petrelli et al.
EXPERT OPINION ON PHARMACOTHERAPY (2010)
Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: Effects of surfactants on particles size, characteristics and in vitro performance
Yutao Liu et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2010)
Benefit of anti-HER2-coated paclitaxel-loaded immuno-nanoparticles in the treatment of disseminated ovarian cancer: Therapeutic efficacy and biodistribution in mice
A. Cirstoiu-Hapca et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Delivering nanomedicine to solid tumors
Rakesh K. Jain et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Drug Delivery Systems for Intraperitoneal Therapy
Gaurav Bajaj et al.
PHARMACEUTICAL RESEARCH (2010)
A self-assembling nanoparticle for paclitaxel delivery in ovarian cancer
Kai Xiao et al.
BIOMATERIALS (2009)
Intraperitoneal administration of paclitaxel solubilized with poly(2-methacryloxyethyl phosphorylcholine-co n-butyl methacrylate) for peritoneal dissemination of gastric cancer
Daisuke Soma et al.
CANCER SCIENCE (2009)
Preclinical and clinical studies of anticancer agent-incorporating polymer micelles
Yasuhiro Matsumura et al.
CANCER SCIENCE (2009)
Different Tissue Distribution of Paclitaxel With Intravenous and Intraperitoneal Administration
Daisuke Soma et al.
JOURNAL OF SURGICAL RESEARCH (2009)
Intra-peritoneal administration of paclitaxel with non-animal stabilized hyaluronic acid as a vehicle - A new strategy against peritoneal dissemination of gastric cancer
Jun Yamada et al.
CANCER LETTERS (2008)
Antitumor Effect of SN-38-Releasing Polymeric Micelles, NK012, on Spontaneous Peritoneal Metastases from Orthotopic Gastric Cancer in Mice Compared with Irinotecan
Takako Eguchi Nakajima et al.
CANCER RESEARCH (2008)
S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial
Wasaburo Koizumi et al.
LANCET ONCOLOGY (2008)
Nanoparticle therapeutics: an emerging treatment modality for cancer
Mark E. Davis et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Nanocarriers as an emerging platform for cancer therapy
Dan Peer et al.
NATURE NANOTECHNOLOGY (2007)
A phase I and pharmacokinetic study of NK105, a paclitaxel-incorporating micellar nanoparticle formulation
T. Hamaguchi et al.
BRITISH JOURNAL OF CANCER (2007)
Limited tissue penetration of taxanes: A mechanism for resistance in solid tumors
Alastair H. Kyle et al.
CLINICAL CANCER RESEARCH (2007)
NK105, a paclitaxel-incorporating micellar nanoparticle, is a more potent radiosensitising agent compared to free paclitaxel
T. Negishi et al.
BRITISH JOURNAL OF CANCER (2006)
Drug penetration in solid tumours
Andrew I. Minchinton et al.
NATURE REVIEWS CANCER (2006)
Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of Cremophor-free, albumin-bound paclitaxel, ABI-007, compared with Cremophor-based paclitaxel
N Desai et al.
CLINICAL CANCER RESEARCH (2006)
Intraperitoneal cisplatin and paclitaxel in ovarian cancer
DK Armstrong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Polymer conjugates: nanosized medicines for treating cancer
MJ Vicent et al.
TRENDS IN BIOTECHNOLOGY (2006)
Polymer conjugates as anticancer nanomedicines
Ruth Duncan
NATURE REVIEWS CANCER (2006)
Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer
WJ Gradishar et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxel
T Hamaguchi et al.
BRITISH JOURNAL OF CANCER (2005)
Preparation and biological characterization of polymeric micelle drug carriers with intracellular pH-triggered drug release property: Tumor permeability, controlled subcellular drug distribution, and enhanced in vivo antitumor efficacy
Y Bae et al.
BIOCONJUGATE CHEMISTRY (2005)
Transduction of soluble Flt-1 gene to peritoneal mesothelial cells can effectively suppress peritoneal metastasis of gastric cancer
A Sako et al.
CANCER RESEARCH (2004)
Treatment of peritoneal carcinomatosis in gastric cancers
C Brigand et al.
DIGESTIVE DISEASES (2004)
Intraperitoneal antineoplastic drug delivery: rationale and results
M Markman
LANCET ONCOLOGY (2003)
Enhanced solubility of paclitaxel using water-soluble and biocompatible 2-methacryloyloxyethyl phosphorylcholine polymers
T Konno et al.
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A (2003)
Paclitaxel and its formulations
AK Singla et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2002)
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
H Maeda et al.
JOURNAL OF CONTROLLED RELEASE (2000)
Share Paper
